GlobeNewswire·Oct 28, 2025, 2:20 PM ET

Prenetics Announces Closing of Approx. $44.0 Million Equity Offering to Fuel IM8's Global Expansion and Bitcoin Treasury Strategy

Prenetics Global Limited closed its best efforts public offering of 2,722,642 Class A ordinary shares & associated warrants at a combined price of $16.08 per share.
The offering included Class A Common Warrants exercisable at $24.12 (50% premium) & Class B Common Warrants exercisable at $32.16 (100% premium), both immediately exercisable for five years.
Gross proceeds totaled approximately $44.0 million, down from the previously announced $48.0 million due to placement agent fees & offering expenses.
Proceeds will fund the global expansion of the IM8 supplement brand & the strategic accumulation of Bitcoin under the company's dual-pronged health & wealth strategy.
Dominari Securities LLC served as the sole placement agent, with Reed Smith LLP acting as counsel to the company.
The securities were issued under a Form F-3 shelf registration statement effective September 11, 2025.
Prenetics' IM8 brand achieved $100 million in annual recurring revenue within 11 months of launch.
As of October 27, 2025, the company holds a total of 275 Bitcoin as part of its corporate treasury strategy.